Neighborhoods have been recognized in theory and research as an important context for child development. This study used data from the Head Start Family and Child Experiences Survey (FACES) and Census 2000 to assess the underlying factor structure and impact of neighborhood factors on child cognitive and behavioral outcomes, including the critical family and social factors that may mediate and/or moderate these relationships. Factor analyses found five factors described Head Start neighborhoods. After controlling for family and child factors, multilevel analyses found significant direct effects of neighborhood factors on Head Start children's cognitive and behavioral outcomes. There were no mediation effects found for family or social variables between neighborhood factors and child outcomes. A large number of moderation effects were found although there was not a clear pattern to the results. Future research, policy, and practice implications are discussed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10464-009-9279-z | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Effect of Coenzyme Q10 on Tinnitus Severity and Sleep Quality in Patients with Presbycusis.
Iran J Otorhinolaryngol
January 2025
Department of Otolaryngology Head and Neck Surgery, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Introduction: Tinnitus is one of the symptoms of presbycusis that affects patients' sleep and social life. This study aimed to determine the effect of coenzyme Q10 (CoQ10) on treating tinnitus due to presbycusis.
Materials And Methods: In this double-blind, randomized clinical trial, 50 patients with tinnitus due to presbycusis were randomly divided into groups A and B, with 25 patients in each group.
GLP-1RA Use and Thyroid Cancer Risk.
JAMA Otolaryngol Head Neck Surg
January 2025
OptumLabs, Eden Prairie, Minnesota.
Importance: The increasing use of glucagon-like peptide-1 receptor agonists (GLP-1RA) demands a better understanding of their association with thyroid cancer.
Objective: To estimate the risk of incident thyroid cancer among adults with type 2 diabetes being treated with GLP-1RA vs other common glucose-lowering medications.
Design, Setting, And Participants: This was a prespecified secondary analysis of a target trial emulation of a comparative effectiveness study using claims data for enrollees in commercial, Medicare Advantage, and Medicare fee-for-service plans across the US.
Masticatory muscle changes on magnetic resonance imaging of dogs with compared to meningoencephalitis of unknown origin.
Front Vet Sci
January 2025
Anderson Moores Veterinary Specialists, Linnaeus Veterinary Limited, Winchester, United Kingdom.
Infectious meningoencephalitides represent an important differential diagnosis for meningoencephalitis of unknown origin (MUO) in dogs. Treatment of the latter requires immunosuppression, but laboratory test results for infectious agents may take several days to return. This study investigated whether the presence of masticatory muscle changes on magnetic resonance imaging (MRI) of the head can be used to distinguish dogs with neosporosis from those with MUO at the time of diagnosis.
View Article and Find Full Text PDFParkinson's disease exacerbation following Levetiracetam administration: an unusual phenomenon.
Oxf Med Case Reports
January 2025
Division of Neurosurgery, Department of Surgery, King Abdulaziz Medical City, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia.
Background: Several studies have investigated the potential beneficial and side effects of levetiracetam on Parkinson's disease (PD). We hereby report a case of PD exacerbation following Levetiracetam administration for seizure prophylaxis.
Case Description: A 77-year-old female, known to have PD, presented with a head injury following a fall.
Conscientious Objection in Healthcare: The Requirement of Justification, The Moral Threshold, and Military Refusals.
J Relig Ethics
March 2024
Institute of Philosophy at Jagiellonian University in Kraków (Poland) and head of the Interdisciplinary Centre for Ethics at Jagiellonian University, where he leads the project BIOUNCERTAINTY funded by a European Research Council (ERC) Starting Grant.
A dogma accepted in many ethical, religious, and legal frameworks is that the reasons behind conscientious objection (CO) in healthcare cannot be evaluated or judged by any institution because conscience is individual and autonomous. This paper shows that this background view is mistaken: the requirement to reveal and explain the reasons for conscientious objection in healthcare is ethically justified and legally desirable. Referring to real healthcare cases and legal regulations, this paper argues that these reasons should be evaluated either ex ante or ex post and defends novel conceptual claims that have not been analyzed in the debates on CO.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!